According to the report, the Latin America Nerve Repair and Regeneration Market Size is valued at USD 1.22 billion in 2022 and estimated to be growing at a CAGR of 12.24%, to reach USD 2.18 billion by 2027 during the forecast period 2022 to 2027.
Factors such as the increasing prevalence of nerve damage, the increase in the elderly population and the successful growth in the incidence of neurological disorders, and the increase in public funding for research on neurological disorders are the factors that are expected to stimulate the growth of the nerve repair biomaterials market during the forecast period. Growing geriatric population, increasing prevalence of neurological and epidemic disorders, and the launch of innovative products for nerve repair and regeneration are other factors affecting in the growth of the Latin America nerve repair and regeneration market.
In addition, the development of markets, the potential of stem cell therapy in nerve repair and regeneration. The increasing incidence of chronic nervous system disorders such as Parkinson's disease and Alzheimer's disease is also stimulating the demand for nerve repair and regeneration procedures and devices. Funding for clinical trials aimed at developing safe and effective therapies for the treatment of various neurological disorders is also increased. Initiatives such as cord blood infusion stem cells for cerebral palsy; and the use of the drug polyethylene glycol (PEG) to promote axonal fusion technique to repair peripheral nerve damage promotes market growth.
Increased research in the field of neurology is aimed at further expanding the profitable opportunities for the growth of the Nerve Repair market during the forecast period.
Factors such as donor site morbidity, issues with treating large nerve gaps, strict governance patterns and time-consuming support procedures, and increased bias for drug therapies rather than nerve repair are expected to limit the rate of growth of the market.
Technological advances in the category of internal neurostimulation and neuromodulation devices are driven by the device's ability to reduce the occurrence of post-surgical complications and the length of hospital stay. Hence, it offers opportunities for market growth in the years to come.
Factors such as validity of regeneration products, shortage of trained professionals, and product recalls are creating challenges in the growth of the nerve repair and regeneration market in the near future.
This research report on the Latin America Nerve Repair and Regeneration Market has been segmented and sub-segmented into the following categories
Mexico is expected to grow at the highest CAGR during the forecast period, due to developments in healthcare facilities and an increase in the number of patients requiring Nerve repair and regeneration components. The factors are responsible for the growth of Mexico in the market where the health of populations is linked to obesity, chronic pain, traffic accidents and many more. All of this has led to a substantial increase in the advancement of technology and devices to deal with these diseases.
Brazil held the leading position due to its well-developed healthcare industry, the presence of leading manufacturers of medical diagnostics, and the increasing number of patients suffering from Alzheimer's disease and other neurological disorders. Argentina is expected to experience good growth as the number of patients with chronic illnesses increases and government initiatives to improve healthcare facilities increase.
The Latin American market in regions of Columbia is expected to benefit from the dramatic increase in an aging population, increased awareness of neurological disorders, and increased incidence of cancer and osteoporosis.
Noteworthy Companies dominating the Latin America Nerve Repair and Regeneration Market Profiled in the Report are Baxter International, AxoGen, Boston Scientific Incorporation, Integra Lifesciences Corporation, Cyberonics, Medtronic, Polyganics B.V., Orthomed S.A.S., Stryker Corporation, and St. Jude Medical.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Internal Neurostimulation Devices
126.96.36.199 Spinal Cord Stimulation
188.8.131.52 Deep Brain Stimulation
184.108.40.206 Vagus Nerve Stimulation
220.127.116.11 Sacral Nerve Stimulation
18.104.22.168 Gastric Electrical Stimulation
5.1.3 External Neurostimulation Devices
22.214.171.124 Transcutaneous Electrical Nerve Stimulation
126.96.36.199 Transcranial Magnetic Stimulation
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2.2 Neurostimulation and Neuromodulation Surgeries
5.2.3 Direct Nerve Repair
5.2.4 Nerve Grafting
5.2.5 Stem Cell Therapy
5.2.6 Y-o-Y Growth Analysis, By Application
5.2.7 Market Attractiveness Analysis, By Application
5.2.8 Market Share Analysis, By Application
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Product
220.127.116.11 By Application
6.1.4 Market Attractiveness Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Product
126.96.36.199 By Application
6.1.5 Market Share Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Product
220.127.116.11 By Application
6.4 Rest of Latin America
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Baxter International
8.3 Boston Scientific Corporation
8.5 Integra Lifesciences Holdings Corporation
8.6 Medtronic PLC
8.7 ST. Jude Medical
8.8 Stryker Corporation
8.9 Orthomed S.A.S
8.10 Polyganics B.V.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.